![Wendy Young](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wendy Young
Director/Board Member at
RAPPORT THERAPEUTICS, INC.
Net worth: 245 880 $ as of 31/07/2026
Profile
Wendy B. Young is currently an Independent Director at Rapport Therapeutics, Inc. since 2024, a Director at Adial Pharmaceuticals, Inc. starting in 2026, and an Independent Director at both Terray Therapeutics, Inc. and Think Bioscience, Inc. Former roles include Chief Executive Officer at Stealth Co. from 2021 to 2023, Senior Vice President-Drug Discovery at Genentech, Inc. from 2018 to 2021, and Executive Partner at MPM BioImpact LLC.
Education includes undergraduate and graduate degrees from Wake Forest University and a doctorate from Princeton University conferred in 1993.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/06/2026 | 6,000 ( 0.01% ) | 245 880 $ | 31/07/2026 |
Wendy Young active positions
| Companies | Position | Start |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Director/Board Member | 07/11/2024 |
| ADIAL PHARMACEUTICALS, INC. | Director/Board Member | 11/06/2026 |
Terray Therapeutics, Inc.
 Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for human diseases using spatially encoded screening optimization platform | Director/Board Member | - |
Think Bioscience, Inc.
 Think Bioscience, Inc. BiotechnologyHealth Technology Develops small-molecule drugs | Director/Board Member | - |
Former positions of Wendy Young
| Companies | Position | End |
|---|---|---|
Stealth Co.
 Stealth Co. Miscellaneous Commercial ServicesCommercial Services Operates as a sustainable personal care company intended to reduce environmental impact | Chief Executive Officer | 02/06/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 02/09/2021 |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Corporate Officer/Principal | - |
Training of Wendy Young
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Adial Pharmaceuticals, Inc.
 Adial Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medications to treat addiction and related disorders | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terray Therapeutics, Inc.
Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for human diseases using spatially encoded screening optimization platform | Commercial Services |
Stealth Co.
Stealth Co. Miscellaneous Commercial ServicesCommercial Services Operates as a sustainable personal care company intended to reduce environmental impact | Commercial Services |
Think Bioscience, Inc.
Think Bioscience, Inc. BiotechnologyHealth Technology Develops small-molecule drugs | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
- Stock Market
- Insiders
- Wendy Young
